Functional morbidity after regional isolated perfusion of the limb for melanoma
β Scribed by A. N. van Geel; J. van Wijk; J. Wieberdink
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 367 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: This retrospective study evaluated the benefit of using tumor necrosis factor (tnf) and melphalan administered via an isolated limb perfusion (ilp) in a series of patients with metastatic melanoma who failed initial ilp with chemotherapeutics. ## Methods: Seventeen patients with ex
Hyperthermic isolated limb perfusion (HILP) with various chemotherapeutic agents has been used for the local treatment of high-grade soft tissue sarcomas (STS) of the extremities, but in most cases, with a disappointing result. Most such regimens certainly should not be considered superior to surger
A 61-year-old man with an intractible and progressively disabling cutaneous non-Hodgkin's lymphoma (NHL) in the lower limb was treated with sequential regional isolated perfusion at 10-day intervals. The first perfusion was hyperthermic (40.2-43.1 "C tumor-temperature); the second was at controlled
Two essentially different methods for physiological evaluation of coronary artery disease were compared in the setting of angioplasty and related to quantitative coronary angiography. Forty-five patients, referred for percutaneous transluminal coronary angioplasty (PTCA), were examined by digital su